Moderate to severe fatigue in patients with interstitial lung disease (FAntasTIGUE-ILD)
- Conditions
- Fatigue, ILD, IPF, Sarcoidosis
- Registration Number
- NL-OMON21789
- Lead Sponsor
- O
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Clinically stable diagnosed pulmonary fibrosis or sarcoidosis (no exacerbation/hospitalization <4 weeks) from the outpatient clinic of the Department of Respiratory Medicine (Zuyderland Heerlen or Sittard)
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
1.Lack of sufficient understanding of the Dutch language;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue, measured by the Cis-Fat (Attachment A), is the primary outcome. The Cis-Fat consists of eight items, scored on a 7-point Likert scale. The range of scores is from 8 (normal fatigue) to 56 (most severe fatigue), with a higher score indicating a higher level of fatigue. Scores ¡Ü26 points indicate normal fatigue, scores 27 to 35 indicate moderate fatigue and scores ¡Ý35 indicate severe fatigue
- Secondary Outcome Measures
Name Time Method Demographic data (as age, gender, lungfunction, medication, etc) and questionnaires (as mMRC, VAS, CAT, EQ-5D-5L, HADS, ADIQ, KWAMOE, FCS, PAM)